BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33813381)

  • 21. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis of bladder cancer by sodium butyrate and cisplatin.
    Maruyama T; Yamamoto S; Qiu J; Ueda Y; Suzuki T; Nojima M; Shima H
    J Infect Chemother; 2012 Jun; 18(3):288-95. PubMed ID: 22041988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
    Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
    Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy.
    Chiba Y; Sato S; Itamochi H; Yoshino N; Fukagawa D; Kawamura H; Suga Y; Kojima-Chiba A; Muraki Y; Sugai T; Sugiyama T
    Int J Gynecol Cancer; 2017 Oct; 27(8):1666-1674. PubMed ID: 28786875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 28. RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-κB in colon carcinoma HCT116 cells.
    Zhang H; Zhang S; He H; Zhao W; Ren K; Chen J; Shao RG
    Cancer Lett; 2011 Sep; 308(1):62-70. PubMed ID: 21570766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.
    Hadad N; Levy R
    Neuromolecular Med; 2017 Sep; 19(2-3):436-451. PubMed ID: 28779377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.
    Piro G; Roca MS; Bruzzese F; Carbone C; Iannelli F; Leone A; Volpe MG; Budillon A; Di Gennaro E
    Mol Cancer Ther; 2019 Aug; 18(8):1405-1417. PubMed ID: 31189612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer.
    Kashiwagi E; Ide H; Inoue S; Kawahara T; Zheng Y; Reis LO; Baras AS; Miyamoto H
    Oncotarget; 2016 Aug; 7(31):49169-49179. PubMed ID: 27322140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
    Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
    Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.
    Weldon SM; Mullen AC; Loscher CE; Hurley LA; Roche HM
    J Nutr Biochem; 2007 Apr; 18(4):250-8. PubMed ID: 16781858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
    Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
    Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptotic activity of the marine diatom Cocconeis scutellum and eicosapentaenoic acid in BT20 cells.
    Nappo M; Berkov S; Massucco C; Di Maria V; Bastida J; Codina C; Avila C; Messina P; Zupo V; Zupo S
    Pharm Biol; 2012 Apr; 50(4):529-35. PubMed ID: 22136301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
    Kubota H; Hirai T; Yamauchi A; Ogo A; Matsumoto H; Ueno T
    Anticancer Res; 2020 Sep; 40(9):5043-5048. PubMed ID: 32878792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells.
    Subramaniam M; Liew SK; In L; Awang K; Ahmed N; Nagoor NH
    Drug Des Devel Ther; 2018; 12():1053-1063. PubMed ID: 29750018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthocyanins Isolated from
    Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.